https://www.avient.com/products/polymer-additives/laser-marking-additives
We have a track record of successfully developing laser marking solutions for a wide variety of applications, materials, and processes.
https://www.avient.com/sites/default/files/resources/PolyOne%25202016%2520Annual%2520Report%2520Web.pdf
Our operations could be adversely affected by various risks inherent in conducting operations worldwide.
In addition, we could be adversely affected by violations of the FCPA, U.K Bribery Act and similar worldwide anti-
bribery laws as well as export controls and economic sanction laws.
We made worldwide income tax payments of $50.3 million and received refunds of $2.4 million in 2016.
https://www.avient.com/sites/default/files/2021-11/avnt-november-investor-meetings.pdf
We are Avient.
6
BETTER TOGETHER: POLYONE AND
CLARIANT COLOR
Key Financial Data (1)
2021E Sales $4.75 billion
2021E EBITDA $580 million
87% of EBITDA from specialty applications
(1) As of October 28, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
CLARIANT COST SYNERGIES
• On-track to realize $50 million of expected
synergies in 2021 – up from earlier estimate of $35
million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
COMPLEMENTARY TECHNOLOGIES AND
CUSTOMERS DRIVE REVENUE SYNERGIES
Revenue synergy opportunities in excess of $50M by 2025
The complementary aspects of our combined businesses are unquestionable.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
We are Avient.
6
BETTER TOGETHER: POLYONE AND
CLARIANT MASTERBATCH
Key Financial Data (1)
2021E Sales $4.3 billion
2021E EBITDA $560 million
2021E Free Cash Flow $275 million
88% of EBITDA from specialty applications
(1) As of April 30, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
7
CLARIANT COST SYNERGIES
• On-track to realize $45 million of expected
synergies in 2021 – up from previous estimate of
$35 million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
COMPLEMENTARY TECHNOLOGIES AND
CUSTOMERS DRIVE REVENUE SYNERGIES
Revenue synergy opportunities in excess of $50MM by 2025
The complementary aspects of our combined businesses are unquestionable.
https://www.avient.com/sites/default/files/2021-09/avnt-seaport-conference-presentation.pdf
We are Avient.
6
BETTER TOGETHER: POLYONE AND
CLARIANT MASTERBATCH
Key Financial Data (1)
2021E Sales $4.6 - $4.7 billion
2021E EBITDA $580 million
2021E Free Cash Flow $280 million
87% of EBITDA from specialty applications
(1) As of July 30, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
7
CLARIANT COST SYNERGIES
• On-track to realize $45 million of expected
synergies in 2021 – up from previous estimate of
$35 million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
COMPLEMENTARY TECHNOLOGIES AND
CUSTOMERS DRIVE REVENUE SYNERGIES
Revenue synergy opportunities in excess of $50MM by 2025
The complementary aspects of our combined businesses are unquestionable.
https://www.avient.com/content/colormatrix-global-email-disclaimers
Explore our worldwide innovation centers, sales offices, regional headquarters, distribution and manufacturing centers
https://www.avient.com/products/polymer-colorants/solid-color-masterbatches
With Avient you have access to a worldwide team of color experts who can help take your idea from pellet to part.
https://www.avient.com/sites/default/files/resources/PolyOne%25202018%2520Proxy%2520Statement.PDF
a medical technology company that focuses on
eliminating pain, speeding recovery, and preventing infection
for healthcare providers and patients worldwide.
He was also Non-
Executive Chairman of Valvoline Inc., a majority-owned
subsidiary of Ashland Global Holdings and a leading worldwide
producer and distributer of premium-branded automotive,
commercial and industrial lubricants and automotive
chemicals, from September 2016 until September 2017.
As of the date of this proxy statement, all
Directors are either meeting, or are on track to meet, the Guidelines.
https://www.avient.com/sites/default/files/2024-03/AS-FILED EF20024640 Avient Corp ARS.pdf
Global Operating Risks
Our operations could be adversely affected by various risks inherent in conducting operations worldwide.
We could be adversely affected by violations of the FCPA, UK Bribery Act and similar worldwide anti-bribery laws,
as well as export controls and economic sanction laws.
GOFF
Former Chairman, President and Chief Executive Officer,
Andeavor
Committees: 3*, 4
NEIL GREEN
Executive Vice President and Chief Digital Officer,
Otis Worldwide Corporation
Committees: 1, 4
WILLIAM R.
https://www.avient.com/sites/default/files/resources/PolyOne%25202012%2520Annual%2520Report.pdf
Our operations could be adversely affected by various risks inherent in conducting operations
worldwide.
In addition, we could be adversely affected by violations of the FCPA and similar worldwide anti-bribery
laws as well as export controls and economic sanction laws.
We made worldwide income tax payments of $30.8 million and received refunds of $13.0 million in
2012.